Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Neuropeptide receptor antagonists |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC25H23F6N5O2 |
InChIKeyACZWFJDLNLZWDP-ZGNKEGEESA-N |
CAS Registry873947-10-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chemotherapy-induced nausea and vomiting | Phase 2 | US | - | |
Cough | Phase 2 | US | - | |
Depressive Disorder, Major | Phase 2 | US | - | |
Nausea | Phase 2 | - | - | |
Nausea | Phase 2 | - | - | |
Urinary Bladder, Overactive | Phase 2 | US | - | |
Vomiting | Phase 2 | - | - | |
Vomiting | Phase 2 | - | - |